The uncertain path to authorisation in the US for Novavax despite passing the efficacy test with an impressive score of 90.4% might see India emerge as a major destination for the shots with the Serum Institute of India as manufacturing partner.from https://ift.tt/3gvSYAh
via IFTTT
No comments:
Post a Comment
Please Leave us a comment about our content, so that we can try improve our site Quality.